<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01191099</url>
  </required_header>
  <id_info>
    <nct_id>NCT01191099</nct_id>
  </id_info>
  <brief_title>Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance</brief_title>
  <official_title>Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center cohort study to identify uni- and multivariate associations between marker
      gene expression and clinico-pathological parameters for the detection of robust and novel
      prognostic tools in prostate cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. To perform a large scale assessment of tissue hypoxia by pimonidazole and hypoxia marker
           gene expression in human prostate cancers

        2. To characterize expression and hypoxia/HIF-responsiveness of myoglobin, cytoglobin,
           α-hemoglobin in prostate tumors and cell lines

        3. To identify uni- and multivariate associations between marker gene expression and
           clinico-pathological parameters for the detection of robust and novel prognostic tools
           in prostate cancers
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Prostate Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pimonidazol</intervention_name>
    <description>0.5gm/m2 Pimonidazol i.v. 16-24 hours before prostatectomy</description>
    <other_name>Hypoxyprobe</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      prostate
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with
        radical prostatectomy at the Department of Urology, University Hospital of Zurich
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with
             radical prostatectomy at the Department of Urology, University Hospital of Zurich

          -  Written informed consent

        Exclusion criteria:

          -  Metastatic prostate cancer

          -  Contraindications to the class of investigational product under study, e.g. known
             hypersensitivity or allergy to the investigational product

          -  Severe heart or lung disease

          -  Severe liver or kidney dysfunction

          -  Severe stridor

          -  Distant metastases

          -  Concurrent treatment for other malignant disease

          -  Prior hormonal therapy or radiotherapy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Müntener, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of urology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zürich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Müntener, MD</last_name>
      <phone>0041 44 255 11 11</phone>
      <email>michael.muentener@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Michael Müntener, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2010</study_first_submitted>
  <study_first_submitted_qc>August 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2010</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

